Anti PD-1/Anti PDL-1 Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Meta-Analysis of Phase 2/3 Randomized Controlled Trials

<b>Importance:</b> Immune checkpoint inhibitors (ICI) have revolutionized the treatment for gastroesophageal cancers (GEC). It is important to investigate the factors that influence the response to anti-PD-1/PD-L1 ICIs. <b>Objective:</b> To assess the benefits of PD-1/PD-L1 ICIs in advanced GEC and...

Descrición completa

Detalles Bibliográficos

Principais autores:	Kanak Parmar, Sai Subramanyam, Kristopher Attwood, Duke Appiah, Christos Fountzilas, Sarbajit Mukherjee
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2022-09-01
Series:	Pharmaceutics
Assuntos:	gastric cancer esophageal cancer gastroesophageal junction cancer immunotherapy
Acceso en liña:	https://www.mdpi.com/1999-4923/14/9/1953
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!